BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37205484)

  • 1. Intermuscular Adiposity is Associated with Coronary Microvascular Dysfunction Independently of Body Mass Index and Modifies its Effect on Adverse Cardiovascular Outcomes.
    Souza AC; Amelie S T; Jan P M; Filipe A M; Sanjay D; Jon H; Ron B; Sharmila D; Marcelo F DC; Florian J F; Viviany R T
    medRxiv; 2023 May; ():. PubMed ID: 37205484
    [No Abstract]   [Full Text] [Related]  

  • 2. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.
    Souza ACDAH; Rosenthal MH; Moura FA; Divakaran S; Osborne MT; Hainer J; Dorbala S; Blankstein R; Di Carli MF; Taqueti VR
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):179-191. PubMed ID: 37768241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients.
    Bajaj NS; Osborne MT; Gupta A; Tavakkoli A; Bravo PE; Vita T; Bibbo CF; Hainer J; Dorbala S; Blankstein R; Bhatt DL; Di Carli MF; Taqueti VR
    J Am Coll Cardiol; 2018 Aug; 72(7):707-717. PubMed ID: 30092946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.
    Taqueti VR; Everett BM; Murthy VL; Gaber M; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
    Circulation; 2015 Feb; 131(6):528-35. PubMed ID: 25480813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.
    Taqueti VR; Solomon SD; Shah AM; Desai AS; Groarke JD; Osborne MT; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
    Eur Heart J; 2018 Mar; 39(10):840-849. PubMed ID: 29293969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
    Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
    Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events.
    Indorkar R; Kwong RY; Romano S; White BE; Chia RC; Trybula M; Evans K; Shenoy C; Farzaneh-Far A
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1686-1695. PubMed ID: 30409558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease.
    Taqueti VR; Shaw LJ; Cook NR; Murthy VL; Shah NR; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
    Circulation; 2017 Feb; 135(6):566-577. PubMed ID: 27881570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Related risk factors of PET/CT detected coronary microvascular disease in patients with chest pain and no obstructive coronary artery disease].
    Wang YD; Chen WQ; Li Y; Li JM; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Nov; 48(11):942-947. PubMed ID: 33210866
    [No Abstract]   [Full Text] [Related]  

  • 11. Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity.
    Koh AS; Murthy VL; Sitek A; Gayed P; Bruyere J; Wu J; Di Carli MF; Dorbala S
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1551-61. PubMed ID: 26012901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry.
    Boerhout CKM; de Waard GA; Lee JM; Mejia-Renteria H; Lee SH; Jung JH; Hoshino M; Echavarria-Pinto M; Meuwissen M; Matsuo H; Madera-Cambero M; Eftekhari A; Effat MA; Murai T; Marques K; Appelman Y; Doh JH; Christiansen EH; Banerjee R; Nam CW; Niccoli G; Nakayama M; Tanaka N; Shin ES; Beijk MAM; Knaapen P; Escaned J; Kakuta T; Koo BK; Piek JJ; van de Hoef TP
    EuroIntervention; 2022 Oct; 18(9):719-728. PubMed ID: 35694826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermuscular adipose tissue and metabolic associations in HIV infection.
    Scherzer R; Shen W; Heymsfield SB; Lewis CE; Kotler DP; Punyanitya M; Bacchetti P; Shlipak MG; Grunfeld C;
    Obesity (Silver Spring); 2011 Feb; 19(2):283-91. PubMed ID: 20539305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death.
    Hong D; Lee SH; Shin D; Choi KH; Kim HK; Ha SJ; Joh HS; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM
    J Am Heart Assoc; 2023 Feb; 12(3):e027690. PubMed ID: 36695307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT.
    Vita T; Murphy DJ; Osborne MT; Bajaj NS; Keraliya A; Jacob S; Diaz Martinez AJ; Nodoushani A; Bravo P; Hainer J; Bibbo CF; Steigner ML; Taqueti VR; Skali H; Blankstein R; Di Carli MF; Dorbala S
    Radiology; 2019 May; 291(2):330-337. PubMed ID: 30835188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial.
    Taqueti VR; Shah AM; Everett BM; Pradhan AD; Piazza G; Bibbo C; Hainer J; Morgan V; Carolina do A H de Souza A; Skali H; Blankstein R; Dorbala S; Goldhaber SZ; Le May MR; Chow BJW; deKemp RA; Hage FG; Beanlands RS; Libby P; Glynn RJ; Solomon SD; Ridker PM; Di Carli MF
    JACC Basic Transl Sci; 2023 Feb; 8(2):141-151. PubMed ID: 36908662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
    Jones E; Wei J; Nelson MD; Bakir M; Mehta PK; Shufelt C; Minissian M; Sharif B; Pepine CJ; Handberg E; Cook-Wiens G; Sopko G; Bairey Merz CN
    PLoS One; 2020; 15(12):e0243213. PubMed ID: 33270715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.
    Bajaj NS; Singh A; Zhou W; Gupta A; Fujikura K; Byrne C; Harms HJ; Osborne MT; Bravo P; Andrikopolou E; Divakaran S; Bibbo CF; Hainer J; Skali H; Taqueti V; Steigner M; Dorbala S; Charytan DM; Prabhu SD; Blankstein R; Deo RC; Solomon SD; Di Carli MF
    Circulation; 2020 Jan; 141(1):21-33. PubMed ID: 31779467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of smoking with abdominal adipose deposition and muscle composition in Coronary Artery Risk Development in Young Adults (CARDIA) participants at mid-life: A population-based cohort study.
    Terry JG; Hartley KG; Steffen LM; Nair S; Alman AC; Wellons MF; Jacobs DR; Tindle HA; Carr JJ
    PLoS Med; 2020 Jul; 17(7):e1003223. PubMed ID: 32692748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.
    Ahmad A; Corban MT; Toya T; Verbrugge FH; Sara JD; Lerman LO; Borlaug BA; Lerman A
    Eur J Heart Fail; 2021 May; 23(5):765-772. PubMed ID: 32949186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.